|
GABPA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68076663698002E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.99760216648792E-15 |
| Normal-vs-Stage2 |
6.26229999999284E-05 |
| Normal-vs-Stage3 |
2.408400E-04 |
| Normal-vs-Stage4 |
1.372200E-02 |
| Stage1-vs-Stage2 |
5.221000E-01 |
| Stage1-vs-Stage3 |
8.302200E-02 |
| Stage1-vs-Stage4 |
3.015600E-01 |
| Stage2-vs-Stage3 |
4.653400E-01 |
| Stage2-vs-Stage4 |
6.238000E-01 |
| Stage3-vs-Stage4 |
9.266600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63358215843346E-12 |
| Normal-vs-AfricanAmerican |
2.56720000813004E-09 |
| Normal-vs-Asian |
9.202900E-04 |
| Caucasian-vs-AfricanAmerican |
4.051400E-01 |
| Caucasian-vs-Asian |
5.229000E-01 |
| AfricanAmerican-vs-Asian |
7.351000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1094237467878E-15 |
| Normal-vs-Female |
6.62090000047577E-07 |
| Male-vs-Female |
3.139800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.16619999715562E-09 |
| Normal-vs-Extreme_Weight |
1.4432899320127E-15 |
| Normal-vs-Obese |
6.75239999470278E-08 |
| Normal-vs-Extreme_Obese |
3.05019998148026E-09 |
| Normal_Weight-vs-Extreme_Weight |
3.050600E-01 |
| Normal_Weight-vs-Obese |
3.128200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.713000E-01 |
| Extreme_Weight-vs-Obese |
2.140100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.533400E-01 |
| Obese-vs-Extreme_Obese |
1.111790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.716320E-02 |
| Normal-vs-Age(41-60Yrs) |
8.36375413371115E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62880819942757E-12 |
| Normal-vs-Age(81-100Yrs) |
1.20159993066693E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.739780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.428100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.036280E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.010300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.466120E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.574180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63924429585904E-12 |
| Normal-VS-Type2 PRCC |
6.21613871487625E-13 |
| Normal-VS-KIRP CIMP |
1.521620E-01 |
| Normal-VS-Unclassified PRCC |
7.68640000536891E-08 |
| Type1 PRCC-VS-Type2 PRCC |
6.219400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.953600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.309800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.021700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.265000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.522300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.72226685638088E-13 |
| Normal-vs-N1 |
1.576220E-01 |
| Normal-vs-N2 |
1.83469999999186E-05 |
| N0-vs-N1 |
4.337800E-03 |
| N0-vs-N2 |
6.907000E-01 |
| N1-vs-N2 |
1.359810E-01 |
|
|
